| Secondary |
| Renal Transplant |
29.0% |
| Drug Use For Unknown Indication |
14.6% |
| Prophylaxis Against Transplant Rejection |
8.7% |
| Product Used For Unknown Indication |
7.9% |
| Rheumatoid Arthritis |
7.2% |
| Pain |
5.3% |
| Hypertension |
3.5% |
| Nausea |
2.8% |
| Thrombosis Prophylaxis |
2.4% |
| Arthritis |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Urinary Tract Infection |
2.2% |
| Immunosuppression |
2.0% |
| Gastroenteritis |
1.7% |
| Prophylaxis |
1.7% |
| Pyrexia |
1.7% |
| Fluid Replacement |
1.3% |
| Mineral Supplementation |
1.3% |
| Pruritus |
1.3% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Toxic Epidermal Necrolysis |
17.5% |
| Urosepsis |
15.7% |
| Pneumonia |
10.8% |
| Somnolence |
6.6% |
| Drug Exposure During Pregnancy |
5.4% |
| Meningitis Enterococcal |
5.4% |
| Pyrexia |
5.4% |
| Tachyarrhythmia |
5.4% |
| Endocarditis |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Urinary Tract Infection |
4.2% |
| Sepsis |
2.4% |
| Alveolitis |
1.8% |
| Nail Discolouration |
1.8% |
| Pancreas Transplant Rejection |
1.8% |
| Substance-induced Psychotic Disorder |
1.8% |
| Weight Increased |
1.8% |
| Dyspnoea |
1.2% |
| Local Swelling |
1.2% |
| Lymphocele |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.0% |
| Drug Use For Unknown Indication |
18.0% |
| Rheumatoid Arthritis |
17.6% |
| Hypertension |
9.7% |
| Renal Transplant |
6.6% |
| Prophylaxis |
4.1% |
| Crohn's Disease |
3.8% |
| Colitis Ulcerative |
3.4% |
| Pain |
3.3% |
| Non-small Cell Lung Cancer |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Coronary Artery Disease |
1.4% |
| Osteoporosis |
1.4% |
| Diabetes Mellitus |
1.3% |
| Osteoporosis Prophylaxis |
1.3% |
| Thrombosis Prophylaxis |
1.2% |
| Depression |
1.1% |
| Premedication |
1.0% |
|
| Urinary Tract Infection |
10.8% |
| Weight Decreased |
8.8% |
| Transaminases Increased |
8.0% |
| Renin Increased |
6.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| Syncope |
5.6% |
| Thrombocytopenia |
5.2% |
| Vanishing Bile Duct Syndrome |
5.2% |
| Vomiting |
5.2% |
| Pyrexia |
4.8% |
| Pneumonia |
4.0% |
| Pulmonary Tuberculosis |
4.0% |
| Renal Failure Acute |
4.0% |
| Septic Shock |
4.0% |
| Agranulocytosis |
3.2% |
| Respiratory Failure |
3.2% |
| Encephalitis |
2.8% |
| Melaena |
2.8% |
| Rash |
2.8% |
| Rhabdomyolysis |
2.8% |
|
| Interacting |
| Prostate Cancer |
29.2% |
| Metastases To Bone |
20.8% |
| Rheumatoid Arthritis |
20.8% |
| Nausea |
16.7% |
| Arthritis |
12.5% |
|
| Melaena |
66.7% |
| Osteonecrosis Of Jaw |
16.7% |
| Potentiating Drug Interaction |
16.7% |
|
